APA (7th ed.) Citation

Tauseef, A., Zafar, M., Silberstein, P., Nahas, J., Frederickson, T., Abodunrin, F., . . . Mirza, M. (2022). Role of daratumumab in relapsed or refractory multiple myeloma patient: A meta-analysis and literature to review. Journal of Family Medicine & Primary Care, 11(6), 2648. https://doi.org/10.4103/jfmpc.jfmpc_1987_21

Chicago Style (17th ed.) Citation

Tauseef, Abubakar, et al. "Role of Daratumumab in Relapsed or Refractory Multiple Myeloma Patient: A Meta-analysis and Literature to Review." Journal of Family Medicine & Primary Care 11, no. 6 (2022): 2648. https://doi.org/10.4103/jfmpc.jfmpc_1987_21.

MLA (9th ed.) Citation

Tauseef, Abubakar, et al. "Role of Daratumumab in Relapsed or Refractory Multiple Myeloma Patient: A Meta-analysis and Literature to Review." Journal of Family Medicine & Primary Care, vol. 11, no. 6, 2022, p. 2648, https://doi.org/10.4103/jfmpc.jfmpc_1987_21.